Irbesartan/Hydroklortiazid Actavis 150 mg / 12.5 mg Норвегия - норвежский - Statens legemiddelverk

irbesartan/hydroklortiazid actavis 150 mg / 12.5 mg

actavis group ptc ehf - irbesartan / hydroklortiazid - tablett, filmdrasjert - 150 mg / 12.5 mg

Irbesartan/Hydroklortiazid Actavis 300 mg / 25 mg Норвегия - норвежский - Statens legemiddelverk

irbesartan/hydroklortiazid actavis 300 mg / 25 mg

actavis group ptc ehf - irbesartan / hydroklortiazid - tablett, filmdrasjert - 300 mg / 25 mg

Losartan/Hydrochlorothiazide Bluefish 100 mg / 25 mg Норвегия - норвежский - Statens legemiddelverk

losartan/hydrochlorothiazide bluefish 100 mg / 25 mg

bluefish pharmaceuticals ab - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 25 mg

Losartan/Hydrochlorothiazide Bluefish 50 mg / 12.5 mg Норвегия - норвежский - Statens legemiddelverk

losartan/hydrochlorothiazide bluefish 50 mg / 12.5 mg

bluefish pharmaceuticals ab - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg

Zofenil Comp 30 mg / 12.5 mg Норвегия - норвежский - Statens legemiddelverk

zofenil comp 30 mg / 12.5 mg

menarini international o.l. s.a. - zofenoprilkalsium / hydroklortiazid - tablett, filmdrasjert - 30 mg / 12.5 mg

Cancidas (previously Caspofungin MSD) Европейский союз - норвежский - EMA (European Medicines Agency)

cancidas (previously caspofungin msd)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika for systemisk bruk - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.